Acta Neuropathologica

, Volume 112, Issue 6, pp 681–689 | Cite as

α-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice

  • Yoshitomo Shirakashi
  • Yasuhiro Kawamoto
  • Hidekazu Tomimoto
  • Ryosuke Takahashi
  • Masafumi Ihara
Original Paper


α-Synuclein is a major constituent of Lewy bodies, the neuropathological hallmark of Parkinson’s disease (PD). Three types of α-synuclein mutations, A53T, A30P, and E46K, have been reported in familial PD. Wild-type α-synuclein accumulates at high concentrations in Lewy bodies, and this process is accelerated with mutated A53T α-synuclein. The accumulation of α-synuclein is thought to be toxic, and causes neuronal death when α-synuclein aggregates into protofibrils and fibrils. Lewy bodies contain not only α-synuclein, but also other proteins including 14-3-3 proteins and synphilin-1. 14-3-3 Proteins exist mainly as dimers and are related to intracellular signal transduction pathways. Synphilin-1 is known to interact with α-synuclein, promoting the formation of cytoplasmic inclusions like Lewy bodies in vitro. To investigate the colocalization of α-synuclein, synphilin-1, and 14-3-3 proteins, we performed immunohistochemical studies on α-synuclein, 14-3-3 proteins, and synphilin-1 in the brain and spinal cord of A53T transgenic mice. In homozygous mouse brains, α-synuclein immunoreactivity was observed in the neuronal somata and processes in the medial part of the brainstem, deep cerebellar nuclei, and spinal cord. The distribution of 14-3-3 proteins and synphilin-1 immunoreactivity was similar to that of α-synuclein in the homozygous mice. Double immunofluorescent staining showed that α-synuclein and synphilin-1 or 14-3-3 proteins were colocalized in the pons and spinal cord. These results indicate that the accumulation of mutant α-synuclein occurs in association with 14-3-3 proteins and synphilin-1, and may cause the sequestration of important proteins including 14-3-3 proteins and synphilin-1. The sequestration and subsequent decrease in 14-3-3 proteins and synphilin-1 levels may account for neuronal cell death.


α-Synuclein A53T transgenic mice Parkinson’s disease 14-3-3 Proteins Synphilin-1 Immunohistochemistry 



We are grateful to Prof. V. M. Lee (Department of Pathology and Laboratory Medicine, University of Pennsylvania) for providing the A53T-Tg mice, and to Prof. E. Iseki (Department of Psychiatry, Juntendo University School of Medicine) for providing the anti-synphilin-1 antibodies.


  1. 1.
    Aitken A (1996) 14-3-3 and its possible role in co-ordinating multiple signalling pathways. Trends Cell Biol 6:341–347PubMedCrossRefGoogle Scholar
  2. 2.
    Avraham E, Szargel R, Eyal A, Rott R, Engelender S (2005) Glycogen synthase kinase 3beta modulates synphilin-1 ubiquitylation and cellular inclusion formation by SIAH: implications for proteasomal function and Lewy body formation. J Biol Chem 280:42877–42886PubMedCrossRefGoogle Scholar
  3. 3.
    Baxter HC, Liu WG, Forster JL, Aitken A, Fraser JR (2002) Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain. Neuroscience 109:5–14PubMedCrossRefGoogle Scholar
  4. 4.
    Berg D, Riess O, Bornemann A (2003) Specification of 14-3-3 proteins in Lewy bodies. Ann Neurol 54:135PubMedCrossRefGoogle Scholar
  5. 5.
    Boston PF, Jackson P, Thompson RJ (1982) Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders. J Neurochem 38:1475–1482PubMedCrossRefGoogle Scholar
  6. 6.
    Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123:383–396PubMedCrossRefGoogle Scholar
  7. 7.
    Chen HK, Fernandez-Funez P, Acevedo SF, Lam YC, Kaytor MD, Fernandez MH, Aitken A, Skoulakis EM, Orr HT, Botas J, Zoghbi HY (2003) Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113:457–468PubMedCrossRefGoogle Scholar
  8. 8.
    Clayton DF, George JM (1999) Synucleins in synaptic plasticity and neurodegenerative disorders. J Neurosci Res 58:120–129PubMedCrossRefGoogle Scholar
  9. 9.
    Conway KA, Harper JD, Lansbury PT (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 4:1318–1320PubMedCrossRefGoogle Scholar
  10. 10.
    Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, Kleiderlein JJ, Margolis RL, Troncoso JC, Lanahan AA, Worley PF, Dawson VL, Dawson TM, Ross CA (1999) Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat Genet 22:110–114PubMedCrossRefGoogle Scholar
  11. 11.
    Eyal A, Szargel R, Avraham E, Liani E, Haskin J, Rott R, Engelender S (2006) Synphilin-1A: an aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from alpha-synucleinopathy patients. Proc Natl Acad Sci USA 103:5917–5922PubMedCrossRefGoogle Scholar
  12. 12.
    Fu H, Subramanian RR, Masters SC (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40:617–647PubMedCrossRefGoogle Scholar
  13. 13.
    George JM, Jin H, Woods WS, Clayton DF (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15:361–372PubMedCrossRefGoogle Scholar
  14. 14.
    Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34:521–533PubMedCrossRefGoogle Scholar
  15. 15.
    Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335:924–930PubMedCrossRefGoogle Scholar
  16. 16.
    Ihara M, Tomimoto H, Kitayama H, Morioka Y, Akiguchi I, Shibasaki H, Noda M, Kinoshita M (2003) Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson’s disease and other synucleinopathies. J Biol Chem 278:24095–24102PubMedCrossRefGoogle Scholar
  17. 17.
    Iseki E, Takayama N, Furukawa Y, Marui W, Nakai T, Miura S, Ueda K, Kosaka K (2002) Immunohistochemical study of synphilin-1 in brains of patients with dementia with Lewy bodies - synphilin-1 is non-specifically implicated in the formation of different neuronal cytoskeletal inclusions. Neurosci Lett 326:211–215PubMedCrossRefGoogle Scholar
  18. 18.
    Kaneko K, Hachiya NS (2006) The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions. Med Hypotheses 67:169–171PubMedCrossRefGoogle Scholar
  19. 19.
    Kawamata H, McLean PJ, Sharma N, Hyman BT (2001) Interaction of alpha-synuclein and synphilin-1: effect of Parkinson’s disease-associated mutations. J Neurochem 77:929–934PubMedCrossRefGoogle Scholar
  20. 20.
    Kawamoto Y, Akiguchi I, Nakamura S, Budka H (2002) Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy. Ann Neurol 52:722–731PubMedCrossRefGoogle Scholar
  21. 21.
    Kawamoto Y, Akiguchi I, Nakamura S, Budka H (2004) 14-3-3 proteins in Lewy body-like hyaline inclusions in patients with sporadic amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 108:531–537CrossRefGoogle Scholar
  22. 22.
    Kawamoto Y, Akiguchi I, Nakamura S, Honjyo Y, Shibasaki H, Budka H (2002) 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J Neuropathol Exp Neurol 61:245–253PubMedGoogle Scholar
  23. 23.
    Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat Genet 18:106–108PubMedCrossRefGoogle Scholar
  24. 24.
    Layfield R, Fergusson J, Aitken A, Lowe J, Landon M, Mayer RJ (1996) Neurofibrillary tangles of Alzheimer’s disease brains contain 14-3-3 proteins. Neurosci Lett 209:57–60PubMedCrossRefGoogle Scholar
  25. 25.
    Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, Billett M, Landon M, Mayer RJ (1988) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson’s disease, Pick’s disease, and Alzheimer’s disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J Pathol 155:9–15PubMedCrossRefGoogle Scholar
  26. 26.
    Marx FP, Holzmann C, Strauss KM, Li L, Eberhardt O, Gerhardt E, Cookson MR, Hernandez D, Farrer MJ, Kachergus J, Engelender S, Ross CA, Berger K, Schols L, Schulz JB, Riess O, Kruger R (2003) Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson’s disease. Hum Mol Genet 12:1223–1231PubMedCrossRefGoogle Scholar
  27. 27.
    Ostrerova N, Petrucelli L, Farrer M, Mehta N, Choi P, Hardy J, Wolozin B (1999) alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci 19:5782–5791PubMedGoogle Scholar
  28. 28.
    Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276:2045–2047PubMedCrossRefGoogle Scholar
  29. 29.
    Ribeiro CS, Carneiro K, Ross CA, Menezes JR, Engelender S (2002) Synphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synuclein. J Biol Chem 277:23927–23933PubMedCrossRefGoogle Scholar
  30. 30.
    Richard M, Biacabe AG, Streichenberger N, Ironside JW, Mohr M, Kopp N, Perret-Liaudet A (2003) Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies. Acta Neuropathol (Berl) 105:296–302Google Scholar
  31. 31.
    Sato S, Chiba T, Sakata E, Kato K, Mizuno Y, Hattori N, Tanaka K (2006) 14–3-3eta is a novel regulator of parkin ubiquitin ligase. Embo J 25:211–221PubMedCrossRefGoogle Scholar
  32. 32.
    Schmidt ML, Murray J, Lee VM, Hill WD, Wertkin A, Trojanowski JQ (1991) Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 139:53–65PubMedGoogle Scholar
  33. 33.
    Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson’s disease. Science 293:263–269PubMedCrossRefGoogle Scholar
  34. 34.
    Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840PubMedCrossRefGoogle Scholar
  35. 35.
    Umahara T, Uchihara T, Tsuchiya K, Nakamura A, Ikeda K, Iwamoto T, Takasaki M (2004) Immunolocalization of 14-3-3 isoforms in brains with Pick body disease. Neurosci Lett 371:215–219PubMedCrossRefGoogle Scholar
  36. 36.
    Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H (2000) Synphilin-1 is present in Lewy bodies in Parkinson’s disease. Ann Neurol 47:521–523PubMedCrossRefGoogle Scholar
  37. 37.
    Xu J, Kao SY, Lee FJ, Song W, Jin LW, Yankner BA (2002) Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med 8:600–606PubMedCrossRefGoogle Scholar
  38. 38.
    Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164–173PubMedCrossRefGoogle Scholar
  39. 39.
    Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87:619–628PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Yoshitomo Shirakashi
    • 1
  • Yasuhiro Kawamoto
    • 1
  • Hidekazu Tomimoto
    • 1
  • Ryosuke Takahashi
    • 1
  • Masafumi Ihara
    • 1
    • 2
  1. 1.Department of Neurology, Graduate School of MedicineKyoto UniversityKyotoJapan
  2. 2.Biochemistry and Cell Biology Unit, Horizontal Medical Research Organization, Graduate School of MedicineKyoto UniversityKyotoJapan

Personalised recommendations